ACAD
47.7
-0.49
-1.02%
AEMD
9.7
+0.2
+2.11%
APRI
1.4
+0.02
+1.45%
ARNA
4.05
-0.01
-0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.41
-0.08
-1.78%
CRXM
0.29
-0.01
-3.33%
CYTX
0.421
-0.005
-1.290%
DXCM
84.93
+0.4
+0.47%
GNMK
8.12
+0.08
+1.00%
HALO
23.31
+0.28
+1.22%
ILMN
214.31
-2.39
-1.10%
INNV
0.158
+0.003
+1.935%
INO
7.15
-0.1
-1.38%
ISCO
0.043
0.00
0.00%
ISIS
55.3
+1.34
+2.48%
LGND
109.31
+0.57
+0.52%
LPTN
0.252
-0.013
-4.8430%
MBVX
1.9
-0.11
-5.47%
MEIP
1.49
0.00
0.00%
MNOV
3.63
-0.1
-2.68%
MRTX
27.82
-0.14
-0.50%
MSTX
0.424
-0.006
-1.441%
NBIX
49.56
+0.57
+1.16%
NUVA
55.58
+0.39
+0.71%
ONCS
5.79
-0.19
-3.18%
ONVO
3.19
-0.16
-4.78%
OREX
3.86
-0.1
-2.53%
OTIC
25.23
-0.74
-2.85%
QDEL
20.85
+0.23
+1.12%
RCPT
228
-0.56
-0.25%
RGLS
7.77
-0.22
-2.75%
RMD
55.9
+0.5
+0.90%
SCIE
0.016
-0.002
-10.5556%
SPHS
0.802
-0.042
-4.976%
SRNE
20.75
-0.42
-1.98%
TROV
7.5
-0.38
-4.82%
VICL
0.65
+0.022
+3.4873%
ZGNX
19.49
-0.11
-0.56%
ACAD
47.7
-0.49
-1.02%
AEMD
9.7
+0.2
+2.11%
APRI
1.4
+0.02
+1.45%
ARNA
4.05
-0.01
-0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.41
-0.08
-1.78%
CRXM
0.29
-0.01
-3.33%
CYTX
0.421
-0.005
-1.290%
DXCM
84.93
+0.4
+0.47%
GNMK
8.12
+0.08
+1.00%
HALO
23.31
+0.28
+1.22%
ILMN
214.31
-2.39
-1.10%
INNV
0.158
+0.003
+1.935%
INO
7.15
-0.1
-1.38%
ISCO
0.043
0.00
0.00%
ISIS
55.3
+1.34
+2.48%
LGND
109.31
+0.57
+0.52%
LPTN
0.252
-0.013
-4.8430%
MBVX
1.9
-0.11
-5.47%
MEIP
1.49
0.00
0.00%
MNOV
3.63
-0.1
-2.68%
MRTX
27.82
-0.14
-0.50%
MSTX
0.424
-0.006
-1.441%
NBIX
49.56
+0.57
+1.16%
NUVA
55.58
+0.39
+0.71%
ONCS
5.79
-0.19
-3.18%
ONVO
3.19
-0.16
-4.78%
OREX
3.86
-0.1
-2.53%
OTIC
25.23
-0.74
-2.85%
QDEL
20.85
+0.23
+1.12%
RCPT
228
-0.56
-0.25%
RGLS
7.77
-0.22
-2.75%
RMD
55.9
+0.5
+0.90%
SCIE
0.016
-0.002
-10.5556%
SPHS
0.802
-0.042
-4.976%
SRNE
20.75
-0.42
-1.98%
TROV
7.5
-0.38
-4.82%
VICL
0.65
+0.022
+3.4873%
ZGNX
19.49
-0.11
-0.56%
Home » Archive by Category

Syndication

Hiring a Research Associate II for Large Biotech Company! (Sorrento Valley)

August 3, 2015 – 2:41 pm

Our nationwide biotech company is searching for a Research Associate II to add to our research team in our office.
6 months temporary opportunity
Monday – Friday 8-5
$16-20/hr. DOE
Providing support to our scientific lab staff with carrying out r […

Quality Associate I/II – BioPhase Solutions – San Diego, CA

August 3, 2015 – 2:35 pm

We are currently looking for a Quality Associate I/II to work for a leading San Diego biotechnology company….$19 – $22 an hour
From BioPhase Solutions – 03 Aug 2015 21:35:45 GMT
– View all San Diego jobs

Sr. Manufacturing Associate – BioPhase Solutions – San Diego, CA

August 3, 2015 – 2:35 pm

Manufacturing Associate – Fill Finish to work for a leading San Diego biotechnology company. BioPhase Solutions specializes in recruiting top talented…$21 – $24 an hour
From BioPhase Solutions – 03 Aug 2015 21:35:44 GMT
– View all San Diego jobs

Undergraduate Summer Research Projects to Be Showcased at UC San Diego Aug. 13

August 3, 2015 – 2:12 pm

More than 300 undergraduates will present faculty-mentored research to peers, professors and the general public at the annual Summer Research Conference on Aug. 13 at the University of California, San Diego. This year’s event will feature presentations focusing on a range of topics including earthworm-inspired robotics and the early cotton industry’s influence on border culture to the blood brain barrier and sea spray aerosols.

Lab Intern – 30 hrs (Camino Santa Fe & Trade)

August 3, 2015 – 2:06 pm

Laboratory Intern — 30 Plus hrs
MicroConstants Inc., a Contract Research Organization (CRO), has an opening for a Laboratory Intern to provide support to the Bioanalytical and Sample Management staff on various activities/projects. Additional respo […

Quality Control Supervisor (Sorrento Mesa)

August 3, 2015 – 1:41 pm

Manage the activities of 1-4 full time Quality Control Analysts and oversee all related GMP release and stability testing, analytical method transfers, validations, and data analysis to support and advance the development of drug candidates.
Respons […

Facility Maintenance Engineer – La Jolla Institute for Allergy and Immunology – La Jolla, CA

August 3, 2015 – 1:39 pm

Inspects and maintains all facility gases located in individual labs.· Provides support to the Receiving Clerk as needed and acts as backup in the Receiving…
From Indeed – 03 Aug 2015 20:39:18 GMT
– View all La Jolla jobs

Halozyme to Host Second Quarter 2015 Financial Results Conference Call

August 3, 2015 – 1:30 pm

SAN DIEGO, Aug. 3, 2015 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2015 on Monday, August 10, 2015 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date post-market, Halozyme will release financial results for the second quarter 2015.

The call will be webcast live through the “Investors” section of Halozyme’s corporate website and a recording will be made available following the call. To access the webcast and additional documents related to the call, please log on to halozyme.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. The live call may be accessed by calling (866) 710-0179 (domestic callers) or (334) 323-7224 (international callers) using passcode 769890. A telephone replay will be available after the call by dialing (877) 919-4059 (domestic callers) or (334) 323-0140 (international callers) using replay ID number 53958140.

About Halozyme
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. Halozyme’s lead proprietary program, investigational drug PEGPH20, applies a unique approach to targeting solid tumors, allowing increased access of co-administered cancer drug therapies to the tumor. PEGPH20 is currently in development for metastatic pancreatic cancer, non-small cell lung cancer, metastatic breast cancer and has potential across additional cancers in combination with different types of cancer therapies. In addition to its proprietary product portfolio, Halozyme has established value-driving partnerships with leading pharmaceutical companies including Roche, Baxalta, Pfizer, Janssen and AbbVie for its drug delivery platform, ENHANZE™, which enables biologics and small molecule compounds that are currently administered intravenously to be delivered subcutaneously. Halozyme is also pursuing clinical collaborations with biopharmaceutical companies including Eisai, to evaluate the pan-tumor potential of PEGPH20. Halozyme is headquartered in San Diego. For more information visit halozyme.com.

Contacts:
Schond Greenway
Halozyme Therapeutics
858-704-8352
ir@halozyme.com

Jim Mazzola
Halozyme Therapeutics
858-704-8122
ir@halozyme.com

Logo – http://photos.prnewswire.com/prnh/20100302/LA63139LOGO

 

SOURCE Halozyme Therapeutics, Inc.

Environmental Tech, Profiling & Manifesting Specialist (United States)

August 3, 2015 – 1:26 pm

Fast paced environmental company seeking hazardous waste characterization, profiling, labeling, & manifesting specialist in San Diego-East County area. 3 years minimum experience in hazardous waste management, 40 hour Haz-woper training & HM 181 cert […]

Cell Culture Associate (San Diego)

August 3, 2015 – 1:23 pm

We are seeking a Cell Culture Associate to work in a growing team here in San Diego. The position includes mammalian cell culture; establishing cell lines, freezing and thawing cells as well as feeding and maintaining them. This position will work wi […